Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $2.82 million.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.